Canopy Health Innovations Provides Operational Update: Provisional Patents and Additional Funding Secured
September 28, 2026
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
September 25, 2026
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
September 22, 2026
Canopy Growth Expands European Medical Cannabis Supply into the UK
Canopy Growth Expands European Medical Cannabis Supply into the UK
September 14, 2026
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
September 8, 2026
Canopy Growth Broadens Australian Medical Cannabis Portfolio with New Formats and Formulations
Canopy Growth Broadens Australia Medical Cannabis Portfolio with New Formats and Formulations
August 17, 2026
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed